Boston Scientific to take Acyst outside the US
This article was originally published in Clinica
Advanced UroScience's injectable bulking agent for stress urinary incontinence, Acyst, will be distributed outside the US by Boston Scientific. Boston will take a percentage of the company as part of the deal. Acyst is a patented pyrolytic carbon micro-bead in a carrier compound. The beads are claimed to be non-migratory, biocompatible, but not resorbable. The compound is used for permanent bulking around the bladder neck. St Paul, Minnesota-based Advanced UroScience has already CE-marked the product.
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.